P reviously published experimental studies have shown contradictory results regarding hemorrhagic shock and its impact on fracture healing. Some suggest that trauma hemorrhage leads to increased osteocyte necrosis and delayed fracture healing [10, 12] , whereas others identified a positive effect of traumarelated hemorrhage on fracture healing [2, 11] .
In the present study, Bundkirchen and colleagues have added another piece of the fracture healing puzzle by using a rodent model to induce a sustained degree and duration of hemorrhage. We know that mouse bone regeneration lasts around 30 days [4] -a hematoma is formed by Day 5 followed by the formation of a soft callus consisting of unmineralized cartilage, a period during which angiogenesis also occurs by Day 10.
The current study, and the previously obtained data by Lichte and colleagues [10] , suggest an effect of hemorrhagic shock on the formation of the callus and in neovascularization. During the first 2 weeks, many of the proinflammatory cytokines (IL-1b, IL-6, TNFa) induce osteoclastogenesis through stimulation of osteoblasts or activated T cells to release RANKL, which interacts with a receptor activator of nuclear factor kB (RANK) on the osteoclast surface leading to osteoclast activation [3, 6] . Hypoxia, induced by hemorrhagic shock, further activates NFkB, which in turn, increases the activation of the inflammatory system and the secretion of IL-1b, IL-6, TNFa. Similarly, hypoxia induces expression of HIF1a, which plays an important role in promoting angiogenesis through VEGF. It appears that hemorrhagic shock dysregulates the ongoing bone healing processes and delays callus formation and neovascularization.
Although the current study found no difference in osseous healing after 2 weeks, this result is far from unprecedented. Similar effects, related to large vessels, can be seen in revascularization following venous thrombosis. Additionally, months after a deep vein thrombosis, revascularization or collateral circulation can be found. I suspect that ischemia-induced coagulopathy may influence local perfusion, which resolves just as revascularization occurs at a microvascular level. In fact, in a large-animal model, our group found a close relationship between these factors and systemic effects [7, 8] . This finding is important, as it underlines the relevance of translational research for bone healing and associated effects.
Where Do We Need To Go?
Systemic inflammation has a major impact on fracture healing, and activating specific immune cell types such as polymorphonuclear (PMN) can harm rodent fracture healing [1, 5] . The detrimental effect of PMNs on bone healing during systemic inflammation was confirmed by the observation of enhanced fracture repair in animals [1] . Additionally, patients with polytrauma had longer fracture healing times, possibly due to the post-traumatic systemic inflammatory response, characterized by rapid proinflammatory cytokine and chemokine release, complement activation, and overactivation of PMNs [9] . It will be important to find out if there is a direct effect of hemorrhage, and if the duration and severity has an impact as well.
How Do We Get There?
Future research should focus on the degree of soft-tissue injuries, the type of fracture fixation in long bones, and the relationship between systemic inflammation and local fracture healing. Ideally, multicenter studies, would consider the effects of each factor and more-precisely identify the roles of hypoxia, local inflammation, and soft-tissue injuries on fracture healing. To do this, several translational and clinical studies will be required. The translational studies would rule out confounding factors, such as local hypoxia, and genetic variations, while the clinical studies would focus on the cofactors addressed in the current publication, the role of stem cells, local osteogenic reactions, and other patientrelated factors.
